ClinVar Miner

Submissions for variant NM_201384.3(PLEC):c.11438G>A (p.Arg3813His)

gnomAD frequency: 0.00005  dbSNP: rs782311906
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000441095 SCV000517450 likely benign not specified 2015-06-04 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Invitae RCV000793945 SCV000933325 uncertain significance Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy 2023-07-20 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 379928). This variant has not been reported in the literature in individuals affected with PLEC-related conditions. This variant is present in population databases (rs782311906, gnomAD 0.03%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 3840 of the PLEC protein (p.Arg3840His).
Illumina Laboratory Services, Illumina RCV001270892 SCV001451673 uncertain significance PLEC-related epidermolysis bullosa 2020-08-03 criteria provided, single submitter clinical testing The PLEC c.11519G>A (p.Arg3840His) variant is a missense variant. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. This variant is found at a frequency of 0.0003260 in the African population of the Genome Aggregation Database. To date, only null variants have been reported in association with autosomal recessive forms of the disease (Pfender et al. 2005). Based on the limited evidence, the p.Arg3840His variant is classified as a variant of uncertain significance for PLEC-related epidermolysis bullosa.
Illumina Laboratory Services, Illumina RCV003985085 SCV004801463 uncertain significance Epidermolysis bullosa simplex, Ogna type 2020-08-03 criteria provided, single submitter clinical testing The PLEC c.11519G>A p.(Arg3840His) variant is a missense variant. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. This variant is found at a frequency of 0.0003260 in the African population of the Genome Aggregation Database (version 2.1.1). To date, only null variants have been reported in association with autosomal recessive forms of the disease (Pfender et al. 2005). Based on the limited evidence, the c.11519G>A p.(Arg3840His) variant is classified as a variant of uncertain significance for epidermolysis bullosa simplex.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.